Across the UK, 12 million people have hearing loss and 1 in 7 adults live with tinnitus. Despite this, there are not yet any clinically approved treatments for those who need and want them.
The RNID Hearing Therapeutics Initiative accelerates the global development of new treatments and therapeutics to prevent and treat hearing loss and tinnitus.
We do this by creating partnerships across the global hearing research ecosystem – from hearing researchers and clinicians, and funders and investors, to those working in biotech, pharma and hearing device companies. If that sounds like you, sign up to join the network below.
How the HTI works
The Hearing Therapeutics Initiative brings together:
- a consortium of partner organisations with unique knowledge, expertise and infrastructure in hearing research, drug discovery and development.
- a global Network of innovators from academia and industry looking for tailored support to help them develop new hearing therapeutics.
The Hearing Therapeutics Initiative connects innovators with the infrastructure and expertise they need, at every step of the translational pathway.
By joining the Network you’ll receive tailored support for your translational research, bi-monthly newsletters with updates on the hearing therapeutics sector, consulting and collaboration opportunities, and invitations to HTI activities and events.
Join the HTI Network
Sign up to the HTI Network
Are you an innovator or investor active in, or interested in entering the hearing therapeutics space? Would you like to stay up-to-date with what’s happening in the sector? Or are you looking for support with your translational hearing project, or access to the HTI virtual research platform? Join the HTI Network – we’d love to hear from you.
Our HTI Network partner organisations
Find out about the partner organisations working with the HTI Network to support innovators developing treatments for hearing loss and tinnitus.
Engaging patients in research
Find out how we can bring about and promote the engagement of patients in research.